Major Depressive Disorder / Anxiety Disorder Secondary to Glaucoma (Primary Open-Angle)

Yes. Under 38 CFR § 3.310(a), any disability proximately caused or chronically worsened by a service-connected condition is itself service-connected. Major Depressive Disorder / Anxiety Disorder is a documented secondary pairing for Glaucoma (Primary Open-Angle) with moderate medical evidence. A nexus letter from a qualified physician linking the two conditions is the most reliable way to establish this connection.

The gold standard is a private nexus opinion stating — to at least a 50% probability ("at least as likely as not") — that the secondary condition was caused or aggravated by the primary service-connected condition. Peer-reviewed medical literature supporting the physiological mechanism strengthens the nexus. Treatment records documenting the onset or worsening of the secondary condition in temporal relation to the primary are supporting evidence.

The VA rates Major Depressive Disorder / Anxiety Disorder separately under its own 38 CFR Part 4 diagnostic code, then combines it with Glaucoma (Primary Open-Angle) and all other service-connected ratings using the combined ratings formula under § 4.25. The formula applies the whole-person concept: a 50% combined existing rating plus a new 30% rating yields 65% (rounded to 70%), not 80%.

38 CFR § 3.310(a) states: "Disability which is proximately due to or the result of a service-connected disease or injury shall be service connected." The aggravation variant under § 3.310(b) applies where the primary condition permanently worsens a pre-existing disability beyond its natural progression. Both standards require a showing of nexus — a medical or scientific link between the primary condition and the secondary.

The medical evidence supporting Major Depressive Disorder / Anxiety Disorder as secondary to Glaucoma (Primary Open-Angle) is rated moderate. Glaucoma produces progressive, irreversible peripheral visual field loss that triggers significant psychological distress. Unlike sudden vision loss, the insidious progression of glaucomatous field loss creates chronic anticipatory anxiety about eventual blindness — a phenomenon distinct from other vision-threatening conditions. Peripheral field loss impairs spatial navigation, driving ability, and fall avoidance, producing functional dependence and social isolation. The treatment burden compounds psychological distress: topical medication side effects (ocular irritation, fatigue), laser procedures, and filtration surgeries create a chronic illness identity. Depression prevalence in glaucoma patients is 10-25%, with anxiety rates of 13-30%, significantly exceeding age-matched controls. Glaucoma medication adherence — critical for preventing progression — paradoxically worsens when depression develops, creating a cycle of disease progression and psychological decline.

The VA will not solicit nexus evidence on your behalf for secondary claims. In practice, a written nexus opinion from a private physician or independent medical examiner is essential — the VA's Compensation & Pension (C&P) examiner is not required to produce a favorable nexus opinion, and the VA has discretion to weigh competing opinions. Submitting a private nexus letter at the time of filing is the most reliable strategy.